Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
HTX-019
.
Show all posts
Showing posts with label
HTX-019
.
Show all posts
Wednesday, December 22, 2021
Submission of HTX-019 (aprepitant) NDA for the Prevention of Postoperative Nausea and Vomiting to FDA
›
Heron Therapeutics, Inc. announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...
›
Home
View web version
